Quantitation of Dna from Wax-embedded Biopsy Tissues Using Two Different Methods by Ariola, Laurie
 QUANTITATION OF DNA FROM WAX-EMBEDDED 
BIOPSY TISSUES USING TWO DIFFERENT 
METHODS 
 
 
                                      By 
                         LAURIE ARIOLA 
Bachelor of Science in Biochemistry & Molecular Biology 
Oklahoma State University 
Stillwater, OK 
2008 
 
Submitted to the Faculty of the 
Graduate College of the 
Oklahoma State University 
in partial fulfillment of 
the requirements for 
the Degree of 
MASTER OF SCIENCE 
July 2012 
 QUANTITATION OF DNA FROM WAX-EMBEDDED 
BIOPSY TISSUES USING TWO DIFFERENT 
METHODS 
 
Thesis Approved: 
 
  Robert Allen, Ph.D. 
  Thesis Adviser 
  Karlis Sloka, D.O  
  Committee Member 
  Ronald Thrasher, Ph.D.  
  Committee Member 
  David Wallace Ph.D. 
  Committee Member 
 Dr. Sheryl A. Tucker 
 Dean of the Graduate College 
 iii 
TABLE OF CONTENTS 
 
                Topic Page  
	   Chapter	  I:	  Introduction	  .................................................................................	  1	  
	   Chapter	  II:	  Review	  of	  Literature	  ....................................................................	  7	  
2.1.	   Frequency	  of	  Misdiagnoses	  ...........................................................................	  7	  
2.1.1.	   Resolving	  Misdiagnoses	  ................................................................................	  8	  
2.2.	   DNA	  Extraction	  from	  Formalin	  Fixed	  Samples	  ...............................................	  9	  
2.2.1.	   Extraction	  Methods	  ......................................................................................	  9	  
2.2.1.1.	   Current	  Protocol	  ..............................................................................................	  11	  
2.2.1.1.	   Sample	  Size	  ......................................................................................................	  11	  
2.2.2.	   Fixation	  .......................................................................................................	  12	  
2.2.3.	   Staining	  .......................................................................................................	  14	  
2.2.4.	   DNA	  Inhibition	  ............................................................................................	  15	  
2.2.4.1.	   Unknown	  Inhibitors	  .........................................................................................	  15	  
2.2.5.	   Degradation	  ................................................................................................	  15	  
	   Chapter	  III:	  Methodology	  ............................................................................	  18	  
3.1.	   Overview	  .....................................................................................................	  18	  
3.2.	   Sample	  Preparation	  .....................................................................................	  19	  
3.3.	   Takara	  DEXPAT	  Extraction	  ...........................................................................	  20	  
3.4.	   Quantitation	  ................................................................................................	  23	  
3.4.1.	   Quantitative	  Template	  Assay	  Technology	  (Q-­‐TAT)	  .....................................	  25	  
3.4.1.1.	   Capillary	  Electrophoresis	  .................................................................................	  28	  
3.4.2.	   Real	  Time	  ....................................................................................................	  29	  
 iv 
3.5.	   Experimental	  Control	  ...................................................................................	  31	  
	   Chapter	  IV:	  Results	  ......................................................................................	  33	  
4.1.	   Measurement	  ..............................................................................................	  33	  
4.2.	   Q-­‐TAT	  Quantities	  .........................................................................................	  36	  
4.3.	   Real	  Time	  Quantities	  ...................................................................................	  38	  
4.3.1.	   Variance	  Among	  Tissue	  Types	  ....................................................................	  40	  
4.3.2.	   Wax	  Removal	  Study	  ....................................................................................	  42	  
4.3.3.	   Inhibition	  Study	  ..........................................................................................	  43	  
	   Chapter	  V:	  Discussion	  and	  Conclusions	  ........................................................	  45	  
5.1.	   Q-­‐TAT	  ..........................................................................................................	  45	  
5.2.	   Real	  Time	  .....................................................................................................	  47	  
5.3.	   Method	  Comparison	  ....................................................................................	  49	  
5.4.	   Tissue	  Type	  Comparison	  ..............................................................................	  51	  
5.5.	   Future	  Research	  ...........................................................................................	  52	  
	   Appendix	  A	  .................................................................................................	  54	  
	   Appendix	  B	  .................................................................................................	  56	  
	   References	  ..................................................................................................	  59	  
 
 
 v 
LIST OF TABLES 
Table                                                                                                                     Page 
Table 1. Tissue Samples                                                                                        20 
Table 2. Slice Measurements                                                                                 35 
Table 3.  DNA Quantities for Q-TAT (HP) and Real Time qPCR                        37 
Table 4. Correlational Analysis of Q-TAT and Real Time Data                           40 
Table 5. Test of Fixed Effects                                                                                42 
Table 6. Tests of Effects Slices                                                                              42 
Table 7. Mean and Standard Error                                                                         43 
Table 8. Wax-Removal Study Quantities                                                              44 
Table 9. Inhibition Study Series Dilution                                                              45 
 
 
 vi 
LIST OF FIGURES 
Figure                                                                                                  Page  
Figure 1.  Effects of Fixation on Nucleic Acids                                        13	  
Figure 2.  Evidence of DNA degradation                                                  17	  
Figure 3.  Spin Column                                                                              22	  
Figure 4.  Extraction Methods                                                                   23 
Figure 5. HP Standard Curve                                                                     27	  
Figure 6. Q-TAT PCR Amplification Parameters                                     29 
Figure 7. Real Time qPCR Amplification Parameters                              32	  
Figure 8. Efficiency Plot                                                                            49	  
Figure 9. Quantitation of Replicate PCR Cycles                                       51	  
 
 vii 
NOMENCLATURE 
Allele The specific form a gene takes at a given position on the 
chromosome, often one of two forms. 
AMEL Amelogenin, referring to the X and Y amelogenin loci identified 
the Q-TAT method. 
Amplification The process of increasing starting DNA to a workable quantity, 
often using PCR. 
Bp   Base pair. 
CAP   College of American Pathologists 
CT The threshold cycle, or a cycle in the exponential phase of Real 
Time PCR at which the software begins quantitating the amount of 
DNA present in a sample. 
DEXPAT A reagent designed by Takara Bio Inc (Shiga, Japan) to streamline 
DNA extraction from paraffin embedded samples. 
DI water Stands for deionized water, meaning that ions found in tap water 
have been removed.  Commonly used in chemical procedures.   
 viii 
DNA Stands for deoxyribonucleic acid, the hereditary material in living 
organisms.  The individuality of DNA among humans allows for 
identification with STR profiling. 
dNTP Stands for deoxyribonucleotide, a single unit of DNA.  A dNTP 
mixture is added to PCR reactions to facilitate the extension of 
template DNA. 
Efficiency  A measure of the rate and productivity of the PCR reaction. 
End-point PCR  A PCR method that quantitates DNA after completion of the 
amplification process. 
FAM A fluorescent dye used to visualize DNA segments. 
FFPE   Stands for “formalin-fixed and paraffin-embedded”. 
H&E Stands for Hematoxylin and eosin.  H&E is a common histological 
stain used on biopsy sections to make pathologic diagnoses. 
µl   Microliter, or 1x10-6 liters. 
µm   Micrometer, micron, or 1x10-6 meters. 
mtDNA Mitochondrial DNA, or DNA found in the mitochondria of the 
cell. 
 ix 
nDNA   Nuclear DNA.  
NED   A fluorescent dye used to visualize DNA segments. 
OSU   Oklahoma State University 
PCR Stands for Polymerase Chain Reaction. By adding specific 
chemicals to a PCR run, DNA can be ‘amplified’ from a small 
amount that is insufficient for analysis to a larger quantity that can 
be successfully examined.  This technique is a widely used method 
for increasing the amount of DNA a sample contains. 
pRL A plasmid found in Renila rentiformis that contains a gene 
encoding luciferase.  Used in Q-TAT to determine if inhibition is 
present.  
Q-TAT Stands for Quantitative Template Assay Technology, and end-
point PCR method developed at OSU Center for Health Sciences. 
qPCR   See Real Time PCR. 
R2 The value that describes how well points on a standard curve plot 
adhere to a line of best fit.  A value of 1.00 indicates a perfect fit. 
Reagent A chemical that is added to a process to bring about a specific 
result. 
 x 
Real Time PCR A PCR method that quantitates DNA during the amplification 
procedure, or in “real time”. 
RFU   Relative Fluorescence Units. 
RNA Stands for Ribonucleic Acid and, like DNA, encodes genetic 
information.  RNA is a single stranded molecule and carries out 
many different functions within the cell. 
STR Stands for Short Tandem Repeat.  STRs are extremely variable 
regions of DNA used to compile human genetic profiles. 
Supernatant Liquid on the surface of a mixture.  Typically suspended over a 
solid (the precipitate), the supernatant can also consist of the upper 
of two liquid layers after centrifugation. 
Template  Here, the original strand of DNA to be amplified in PCR.  
Quantitation Method A scientific technique used to determine how much of a substance 
exists; here, DNA. 
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 Chapter	  I	  
Introduction	  
 
Millions of biopsies are performed each year, many leading to life-altering 
diagnoses.  As a result of multi-phase processing and handling by different individuals, 
biopsy samples that form the basis for these diagnoses are subject to contamination.   
While error is expected in human tasks, every precaution should be taken to minimize 
and safeguard against it.  Identifying contamination or other errors when they do occur is 
of the utmost importance.  To that end, this study will seek to accomplish two goals: The 
first is to reliably and accurately extract DNA from biopsy tissues for identification 
purposes, and the second to compare two quantitation methods to examine which is more 
suitable for quantitating these DNA extracts. 
Discovering a contamination event is challenging on many levels, and as such, 
exact rates of occurrence are hard to pin down.   In a 1996 study conducted by the 
College of American Pathologists (CAP), contamination was estimated to occur in up to 
22% of cases.1 Lab procedures have improved in the years since the CAP study was 
published, but foreign tissue in biopsy sections is nevertheless still a concern.2 Some 
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forms of cross-contamination do not result in an incorrect diagnosis, and therefore will 
not indicate an error has occurred.  However, the contamination of tissue from a cancer-
free individual with a cancerous one could have serious health consequences for both 
patients.  Misdiagnosing an individual with cancer based on a contaminated biopsy 
sample may result in extreme and unnecessary treatments such as surgery, radiation 
therapy, or chemotherapy.  
Many stages of biopsy analysis, from sample collection to slide preparation, offer 
an opportunity for contamination.  This study grew out of an event in which the 
Oklahoma State Center for Health Sciences (CHS) forensic department was asked to 
analyze biopsy tissue suspected of contamination.  A patient was diagnosed with uterine 
cancer on a biopsy.  A hysterectomy was performed and no evidence of cancer was found 
in the uterus.  CHS received glass slides of the original uterine biopsy, and extracted 
DNA from the slides to compare with the patient’s DNA.  The original uterine biopsy 
was found to contain DNA from more than one individual, confirming contamination had 
occurred.  The origin of the other DNA profile in the sample could not be determined 
even after comparing the profile to numerous other samples that had been processed the 
same day as the original tissue.  
This particular contamination event may have resulted from cancerous tissue 
being accidentally picked up onto a slide with tissue of the cancer-free patient.   Most 
likely, the water bath used to float the paraffin strip after cutting was not thoroughly 
cleaned between uses, and a piece of cancerous tissue (called a “floater”) from a 
preceding patient may have remained in the water bath.  Unknowingly, the technician 
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may have picked up two types of tissue onto one slide resulting in a slide sample with 
DNA from two separate individuals.  
 Resolving contamination events is time-consuming and cumbersome, and quality 
controls are in place in all hospitals to try to prevent their occurrence.  However, these 
guidelines may not be followed to the letter if a technician is rushed by being over-
worked, or not following procedures.  Contamination can also occur prior to slide 
preparation, for example, a contaminant may be embedded in the wax block with the 
original sample.  Embedding tissues in blocks of paraffin wax is customary, and the wax 
block serves as the preserved source from which sections can be prepared for 
microscopic examination. Contamination of wax blocks is harder to detect than the odd 
piece of floating tissue, as it can appear throughout all or multiple slides rather than being 
only on one slide.1 Mislabeling samples represents a third important form of 
contamination.   
STR-DNAa typing methods can rapidly detect contamination (reflected as DNA 
profiles from more than one individual), provided adequate amounts of DNA are 
recovered from the slide or wax blocks.  Therefore the need for successful DNA 
                                                
 
a Short tandem repeats (STRs) are highly variable, repeating segments of the 
genome.  The repeats are generally 3 or 4 base pairs in length.  STR variability is 
capitalized on in DNA profiling.  The locations of variability are first targeted by primers 
that are specific for a given genomic sequence and then amplified, or multiplied, using 
PCR (section 3.4.1 Quantitative Template Assay Technology).  Certain STRs are common 
among about 5-20% of the population, so by using 13 genomic locations the individuality 
of a set of STRs (the genetic profile) can be determined.  
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extraction from paraffin embedded tissues is critical not only for identification purposes 
but also for many other applications involving DNA analysis.  For example, gene 
analysis is crucial to cancer research, yet fresh tissue can be difficult to obtain, especially 
in large quantities and over short time periods, as are often necessary for research.  
Paraffin-embedded tissue offers a resource of cancerous tissue that is suitable for many 
purposes if DNA can be successfully extracted.3 Archived tissues may useful for 
mutation screening3 or the detection of pathogens4. In addition, DNA analysis is currently 
being used to direct personalized cancer treatments.   
STR-DNA analysis is the primary method used to associate unknown biological 
material, including that found in a biopsy sample, with an individual.  STR profiling 
involves examining chromosomal “addresses” within the genome, called loci, which vary 
from person to person.  The frequency of each allele at each locus in a given population is 
known.  STR results produced from several of these variable loci are then combined 
statistically to indicate the likelihood that a biological sample belongs to a specific 
person. Tissue samples representing biopsies can be genetically analyzed in this manner 
to indicate the person from whom the sample originated.  Moreover, this analysis will 
reveal if more than one person contributed to the sample—a clear indication of 
contamination. 
Knowing that contamination does occur, a worst-case scenario would include the 
failure to detect such an event.  Successfully extracting DNA from biopsy samples is vital 
to contamination resolution, but may be prohibited by limitations in DNA quantity, poor 
PCR amplification, inhibition, or sample degradation.  Therefore, the over-arching goal 
of this study was to critically examine and possibly enhance DNA extraction and 
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quantitation from biopsy samples.   We examined ways to reliably extract and quantify 
biopsy samples—keeping in mind the limitations involved—regardless of how the tissues 
were processed.  A method to accurately quantify the amount of DNA that should be 
expected from a biopsy of a given size would greatly assist labs faced with using slides or 
wax blocks for DNA-based tests.  Improving extraction and quantitation methods could 
help achieve the maximum DNA yield from histological specimens in order to generate 
an STR profile from this sample type.  
Past studies cover DNA extraction methods for tissue embedded in paraffin 
wax.5,6,7 Processes for paraffin embedding vary, as do post-paraffin treatments with dyes, 
fixatives, and stains.  While an optimal extraction method for every type of fixation is 
beyond the scope of this study, the methods most likely to be used will be examined in 
depth.  
Multiple facets of the extraction process will be examined.  Tissue samples must 
be measured, as the amount of starting material generally determines the quantity of 
resultant DNA.  The type of tissue from which DNA is recovered should also be 
considered.  Different tissue sources may yield more or less DNA, owing to structural 
characteristics of the tissues themselves.  Additionally, wax was removed from some 
samples to observe the effect of wax on DNA yield.  Finally, two methods of DNA 
quantitation were studied, as genetic profiling largely depends on reliable quantitation of 
unknown samples.  The ability of a technique to accurately quantitate yield is as 
important as the extraction method.  DNA recovery was quantified using two extraction 
methods that both center on the polymerase chain reaction (PCR).  PCR has become an 
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integral part of any analytical method involving nucleic acids.  In this study, both Real 
Time and post-amplification quantitation methods were employed.  
Six tissue types were utilized in this study; four main tissues examined were of 
the colon, liver, lung, and breast, as they represent the most common biopsies performed.  
Additionally, brain and kidney biopsies were examined, though less intensely.  Focusing 
our study on tissues commonly examined in the pathology laboratory made obtaining 
adequate numbers of samples easier and also ensured that our results were applicable to 
the widest population of patients. 
Developing the DNA extraction and quantitation process may be beneficial in 
certain high-cost situations: Loss of life, such as wrongful death, or litigation brought 
against a hospital may warrant cost-effective DNA profiling.  Insight into the extraction 
process may also benefit current research practice by ensuring that technicians are 
receiving the maximum amount of yield from a biopsy sample presented to their 
laboratory. 
 
  Chapter	  II	  
Review	  of	  Literature	  
An in-depth review of current literature on formalin fixed paraffin embedded 
(FFPE) tissue was conducted prior to beginning this study.  The review focused on 
foundations of DNA extraction from paraffin, and the application of this technique for 
possible diagnosis and treatment as well as current extraction methods.  
The goal of this literature search was to determine where any gaps in knowledge 
exist concerning DNA extraction from wax-embedded samples.  It is important to place 
research in the context of what has already been done, so that it will enhance the body of 
knowledge and further science as a whole.  Additionally, the search serves to expose 
limitations in previous studies to determine if they can be overcome through further 
experimentation or if they were simply inherent in the research procedure. 
2.1. Frequency of Misdiagnoses 
One application of STR-DNA analysis that relies on extraction from biopsied 
tissue is in the detection of DNA foreign to the patient, a result consistent with 
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contamination.  As in the case of uterine biopsy tissue sent to CHS, contamination can 
lead to an incorrect diagnosis. When an incorrect diagnosis does occur, the results are 
often profound.  If the patient proceeds with a surgical removal of the cancerous region or 
tumor, the treated area may end up disfigured or non-functioning.  In some cases surgery 
can result in complications leading to additional illnesses or death. b,8  Preventing 
unnecessary surgery or chemotherapy treatment is of the greatest concern; implementing 
genetic examination of suspect samples could assuage this concern. 
2.1.1. Resolving Misdiagnoses 
When a patient is misdiagnosed with cancer the error is usually discovered at 
some treatment phase.  Post-surgical gross or microscopic analysis can expose the 
excised mass as healthy or even as a different disease.2 The patient may have experienced 
mental anguish and some physical trauma as a result of the ordeal.  After a misdiagnosis, 
the hospital may choose to review their procedures internally. 
Recovering from an erroneous diagnosis will be difficult for a hospital.  Patients 
facing cancer and a major surgery have likely taken measures to prepare for death, 
informed family members of their status, and battled psychological distress.  The pain 
and suffering associated with a cancer pronouncement, compounded by the hospital’s 
desire to avoid negative publicity, could result in a large settlement for a misdiagnosed 
                                                
 
b While contamination is rare in biopsied tissues, other medical tests such as those 
requiring cytological specimens experience a higher frequency of contamination.  Many 
of the principles discussed in this study, like areas where contamination may occur, could 
also be at issue in other diagnostic or therapeutic processes. 
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patient.  Regardless of the outcome, misdiagnoses are never a small incident and are 
upsetting for all involved. 
2.2. DNA Extraction from Formalin Fixed Samples 
Before any tissue sample can be genetically analyzed, the DNA must first be 
released from its cellular environment.  In addition to the cellular constraints, DNA in 
biopsied tissue samples is fixed in 10% formalin—formaldehyde dissolved in water— for 
the purpose of maintaining the cellular structure so it can be examined microscopically.  
Formalin-fixed DNA must therefore be ‘unfixed’ as well as released from the cell.  This 
process of releasing DNA is known as extraction, and can be accomplished in a number 
of ways.  Most extraction methods consist of variations upon the same steps, and finding 
the optimal process is often accomplished through trial and error.   
DNA extraction from formalin fixed samples has been the subject of research for 
decades, but a universally accepted method has not yet been established.  Technicians 
prefer different methods based on both their personal techniques and the materials they 
are working with.  Some conditions required by a particular extraction method may not 
be practical for all sample types or workplace environments.  Regardless of personal 
preference, a few established methods do consistently yield better results than others.   
2.2.1. Extraction Methods 
Paraffin-embedded samples have been subjected to numerous extraction protocols 
in an attempt to determine optimal conditions.  While technicians commonly use 
commercial kits for simplicity, other extraction techniques can surpass kits’ quality in 
terms of yield of DNA or overall suitability for PCR amplification.10 We will be using a 
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kit for this study because it is a proven method, yields reproducible results, and is cost-
efficient.  Research on paraffin-embedded DNA extraction frequently uses a kit to ensure 
equal treatment of all samples, while a separate aspect of the process not involving kit 
reagents is altered as the variable. 
Another extraction procedure occasionally used for biopsy samples, phenol-
chloroform extraction, takes advantage of the different solubilities of cellular components 
such as proteins, lipids, and DNA.c  DNA is successfully separated from other 
components with this method, however it requires several steps and can be time-
consuming.  Additionally, the reagents are somewhat more toxic than those in other 
methods.  In one extraction study, Elena Rivero of the Federal University of Santa 
Catarina, Floriano´polis, SC, Brazil compared a salting-out method with phenol-
chloroform extraction and found that the results for both methods were comparable.4  The 
salting-out procedure required fewer steps and less-toxic chemicals.  Shan-Rong Shi of 
the University of Southern California Keck School of Medicine examined extraction a 
varying pH levels, and found that extraction is most efficient at a pH around 9.6 These 
techniques and variations should be taken into consideration when optimizing extraction. 
                                                
 
c Phenol-chloroform extraction is a liquid-liquid extraction method commonly 
used in many forensic and research facilities to isolate DNA.  While it can be 
cumbersome, the technique has persisted due to its ability to yield clean nucleic acid, free 
of protein or other macromolecules.  Initially, lipids and proteins are lysed, and 
subsequent steps isolate DNA from other cellular material by separation into organic and 
aqueous phases.  This technique can also be used to isolate RNA or DNA.11 
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2.2.1.1. Current Protocol 
Currently, Oklahoma State University Center for Health Sciences (CHS) utilizes 
the TaKaRa DEXPAT kit to extract DNA from tissue samples (Takara Bio Inc, Shiga, 
Japan).  DEXPAT is considered to be a high-quality method of DNA extraction from 
paraffin wax.  This procedure requires a heating step followed by centrifugation, after 
which the supernatant containing DNA is removed and ready to be amplified.  DEXPAT 
prepares DNA for PCR amplification quickly by eliminating a deparaffinizing step 
common in other extraction methods.  Deparaffinizing is not essential for recovery of 
high quality DNA, but some find that it improves the yield and/or quality of their 
extractions.d While the quality of DNA may be higher, the disadvantage of removing 
paraffin is that some tissue is inevitably lost along with the wax, thereby decreasing the 
final DNA yield.  For the purposes of this study, retaining DNA was more important than 
purifying it, keeping in mind the ultimate goal of generating an STR profile. 
2.2.1.1. Sample Size 
Selecting the appropriate sample size for analysis is vital as it determines the 
quantity of DNA that can be potentially recovered.  Deciding how much tissue to use can 
be complex.  Large samples may actually yield less DNA suitable for amplification than 
                                                
 
d Deparaffinizing dissolves paraffin wax in order to expose cells for lysis.  
Typically performed with Xylene, a number of hydrophobic solvents can actually be 
used.  When deparaffinization is incorporated into an extraction method like DEXPAT, 
sample retention is higher due to eliminating tube transfers and multi-step procedures.8 
Deparaffinizing can also be carried out by heating and cooling the sample so that the 
paraffin adheres to the tube, although conventional wisdom suggests that tissue in 
samples with a large amount of paraffin will not be successfully removed. 
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smaller samples, due to the introduction of PCR inhibitors into the extract.  Examining 
the correlation between sample size and yield may serve as a guide for selecting 
appropriately sized samples if certain tissue types are consistently more degraded than 
others, or if DNA yield is affected by age of the sample or presence of inhibitors.   
Sections cut from wax blocks are commonly between 5µm and10µm thick.  This 
range is fairly consistent across the field, as smaller sizes may be beyond the lower limit 
of analysis and larger samples are not always available.  The availability of larger slices 
is limited because biopsy sections more than 10µm thick are not suitable for microscopic 
analysis.  So, as in the case of the aforementioned CHS study, when researchers must 
work with slices on glass slides they seldom come across samples thicker than 10µm.  To 
recreate these real-world limitations, this study used sections 10µm thick. 
2.2.2. Fixation 
The fixation process may lead to chemical modifications that bring about base 
changes and lessen the overall stability of the DNA molecule.7 Furthermore, prolonged 
fixation increasingly cross-links proteins and the double helix over time (Figure 1).  This 
may affect development of a DNA profile, as longer sections of the genome may not 
correctly amplify due to the damage caused by cross-linkages.  After analysis, tissues that 
have been more severely cross-linked show increased fragmentation.11  
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Figure 1.  Effects of Fixation on Nucleic Acids 
Purification of DNA extracted from paraffin embedded sections is limited 
by the length of fixation, with longer fixation times leading to a steep 
increase in cross-links.   The result of extensive cross-linking is often 
evidenced by limitations of purification of the final DNA product.8  
Multiple studies show that formalin fixation can prevent complete lysis of cells 
during extraction.8,12 Some fixative formulas have been shown to minimize some of the 
degradation that occurs with formalin fixation, but they are conversely much worse for 
use in histological analysis and also more labor-intensive to produce.13 Because the 
primary purpose of tissue fixation is diagnostic pathology, it is unlikely that the switch to 
more DNA-friendly fixatives will be made unless one is proven to be as effective as 
formalin.  Other fixatives, such as picric acid, destroy DNA entirely, but make tissues 
extremely receptive to acid dye staining.14 While the search for the perfect fixative has 
yet to be identified, fixed tissue samples are still preferable to non-fixed samples, as they 
are somewhat more protected from degradation during subsequent paraffin embedding.15 
Further complicating fixation, different tissue types may require different fixation 
times or procedures.  The softer consistency of breast tissue, for example, may necessitate 
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a longer fixation time than other tissues, which leads to the potential for increased 
fragmentation of DNA from this source.11 Variation among tissue treatment supports the 
evaluation of a wide range of tissue types in this study.  
As an aside, fixation may affect mitochondrial DNA (mtDNA) differently than 
nuclear DNA.  Literature suggests that mtDNA may be more resistant to the effects of 
formalin fixation that nuclear DNA.  In future studies, repeating tests with mtDNA could 
substantially affect results.13 
2.2.3. Staining 
Biopsy samples are usually stained for microscopic analysis, in order to increase 
the visual contrast of different cellular components.  This contrast aides the pathologist in 
making an appropriate diagnosis.  Hematoxylin and eosin (H&E)e is the most widely 
used stain in histology.16 This acidic dye binds to nuclei, but may also alter the cell in a 
manner that affects DNA extraction.  A study performed by Joanne Simons of the 
Institute of Environmental and Science Research found that H&E staining had an 
immediate effect on DNA recovery.  However, the DNA yield from ten-week old stained 
samples was not significantly different than non-stained samples.18 More research into 
the effects of staining on DNA yield is needed, but current literature supports the theory 
                                                
 
e Hematoxylin, oxidized and complexed with aluminum ions, forms hemalum, 
which colors cellular components—namely nuclei—blue.  Eosin Y (bromide oxidized by 
fluorescein) counterstaining then colors cytoplasm and extracellular proteins shades of 
red.17  
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that it does negatively affect amplification—and possibly DNA recovery—to some 
extent. 
2.2.4. DNA Inhibition 
Inhibition occurs when an external agent interferes with DNA amplification.  
Inhibitors can be chemicals used when fixing DNA, such as formalin, or chemicals used 
for analyzing tissue sections, like stains.  These agents may block PCR altogether or 
cause amplification to proceed more slowly by altering or degrading a portion of the 
genetic material.19 Inhibitors can reduce the amplification yield by lowering the overall 
amount of DNA produced, or by binding to DNA template thereby reducing its 
availability for amplification.20 
2.2.4.1. Unknown Inhibitors 
Like DEXPAT, several DNA extraction methods do not require a deparaffinizing 
step, yet some researchers have found it to be vital for removing unknown inhibitors.21 
One such study, performed with unstained samples, systematically eliminated known 
inhibitors, so researchers determined that PCR inhibition may have been cellular in origin 
rather than attributable to an external source.7  More research needs to be done to 
pinpoint what kinds of cellular PCR inhibitors exist. 
2.2.5. Degradation 
Physically, degradation is the breaking down of the components of the DNA 
molecule.  Depurination, one cause of degradation, is the removal of a purine base (either 
adenine or guanine) from the sugar “backbone” of the molecule.  Depurination can be 
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induced by heat or acidity and precedes separation of the adjacent phosphodiesterf 
bonds.23 In this form, DNA can no longer be amplified or analyzed. 
Degradation is a common source of poor amplification when working with older 
or otherwise compromised samples.  DNA can degrade for a variety of reasons, many of 
which are due to storage in a hostile environment.  While nucleic acids can tolerate a 
broad range of environmental conditions, exposure to excessive heat, moisture, or acidity 
will cause DNA to break down into fragments that cannot be successfully analyzed.  
Because STR analysis requires DNA templates of specific lengths (comprising the panel 
of different STR loci), any alteration of template length by fragmentation will yield 
inaccurate results.  These degradation effects can be somewhat ameliorated by analyzing 
shorter genomic segments because they degrade more slowly than longer DNA strands. 
The effects of DNA degradation mimic those of low-yield DNA, but can be 
recognized in analysis by the characteristic downward slope across the 
electropherogram24 (Figure 2).  
                                                
 
f A phosphodiester bond is characterized by covalent bonding of a phosphate 
group in the pentose (five-carbon) sugar of one nucleotide in a DNA strand to the 
hydroxyl (OH) group in the pentose sugar of an adjacent nucleotide.   
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Figure 2.  Evidence of DNA degradation 
Degradation can be seen when profiling DNA, as in the top 
electropherogram17, obtained from a sample of DNA that had been heated 
in an oven for one month at 56°C.  While the peaks on the left side of the 
figure are high enough to adhere to allele-callings guidelines, they slope 
downward to the right across the image, indicated by the red line, finally 
falling below the threshold. The lower electopherogram24 displays a 
normal non-degraded profile. 
 
Aside from degradation of FFPE tissue, studies suggest that any extract 
from these tissues may begin to degrade immediately after extraction.  For this 
reason, extracts should be quantitated as rapidly as possible.  Takara Bio claims 
that DEXPAT extracts can be stored for “up to 3 months at 4°C and up to 1 year 
at -20°C”. 25 So, while it was not a main focus in this study, time sensitivity of the 
extracts was taken into consideration in this study in order to prevent extract 
degradation from altering results. 
  Chapter	  III	  
Methodology	  
3.1. Overview 
As previously stated, one goal of this study was to assess methods of reliably 
extracting DNA from wax embedded biopsy samples.  Factors that may inhibit or reduce 
DNA yield were a main focus, and included: the size of the biopsy sample; the effect of 
paraffin wax on extraction and/or PCR amplification; tissue type, and PCR inhibition.  
One specific question addressed in this study was whether or not a relationship exists 
between sample size and the amount of DNA recovered from that sample.  While 
seemingly an obvious correlation, the two may not relate as expected.  Examining tissue 
size vs. DNA yield also opened the possibility of determining an average amount of DNA 
recovered per cubic micron of sample material.  
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3.2. Sample Preparation 
Biopsied tissues are commonly fixed in formalin and embedded in wax for 
preservation and microscopic examination.26 Formalin cross-links the cell structures so 
that they do not change or degrade prior to microscopic analysis.26 Most hospitals use a 
10% buffered formalin solution for fixation.  However, the length of fixation times vary 
widely10, while the penetration rate of formalin through the tissue is fairly constant at 
about 1mm per hour26.  After fixation, the sample is dehydrated so that all of the water in 
the tissue is replaced with hardened wax.  Dehydration is generally performed with 
ethanol; the dehydrating agent is gradually replaced with paraffin in several successive 
liquid-changing steps, each of an increasing concentration. 
Samples for this project were obtained from the OSU Medical Center, already 
formalin-fixed and embedded in paraffin wax blocks.  These samples had been stored 
past the length of time required by patient record regulations (10 years) and could 
therefore be discarded by the hospital.  Tissue samples from individuals diagnosed with 
common cancer types were selected—primarily lung, breast, colon, and liver—so that the 
study would apply to as broad a patient population as possible. 
In total, twenty-one wax blocks from the OSU Medical Center were selected 
(Table 1).  For purposes of this research, the tissue needed to resemble as closely as 
possible actual conditions in which a lab might receive a biopsy sample.  The blocks were 
sent to Regional Medical Laboratories (RML) to be cut into 15 slices at 10µm thick, put 
on positive charge glass slides, and air-dried.  Each section was stored at room 
 20 
temperature until DNA extraction and quantitation.  DNA extracts were subsequently 
stored at 4°C. 
Table 1 Tissue Samples 
 
This table lists each biopsy sample obtained from the OSU Medical 
Center, along with all of the information known about that sample.  While 
many biopsies contained information on the gender and age of the patient, 
several did not, yet the information was retained out of interest.  The 
diagnoses made based on these biopsies were primarily malignant. 
 
3.3. Takara DEXPAT Extraction 
The TaKaRa DEXPAT DNA extraction kit is distributed by the Japanese 
company, Takara Bio Inc (Shiga, Japan), and is specifically formulated to optimize DNA 
extraction from tissues that have been formalin-fixed and embedded in paraffin wax.  
Wax complicates biological tissue extraction, as paraffin may inhibit the effectiveness of 
some extraction reagents.  Additionally, if all of the wax is not removed, traces left 
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behind can interfere with DNA amplification and STR analysis.  An extraction process 
like DEXPAT that is designed to work with paraffin wax claims to enhance final DNA 
yield and quality. 
The procedure for DEXPAT extraction is very straightforward.  DEXPAT 
extracts DNA in one step, meaning there is no need for an initial wax removal step.  
Instead, DNA is extracted from both the wax and the cell simultaneously.  Five tissue 
sections of the desired size (in this case 10µm thick) were placed in a 1.5ml microfuge 
tube.  Next, twenty drops of DEXPAT extraction reagent (about 0.5ml) were added to 
each tube.  These tubes were heated at 100°C for 10 minutes, followed by centrifugation 
at 12,000 rpm and 4°C for 10 minutes.  Centrifugation separates the DNA extract from 
melted paraffin, cellular components, and the DEXPAT reagent.  After centrifugation, a 
top layer of paraffin, hardened by exposure to low temperatures, was punctured with a 
pipette tip and the supernatant below transferred to a clean tube.  The precipitate was 
discarded. 
A process to further purify the DNA and capture it in a small volume followed the 
extraction procedure.  Using the Zymo Genomic Clean and ConcentratorTM kit (Zymo 
Research, Orange, CA), the extract was first mixed with the kit’s DNA Binding Buffer, 
which facilitates the binding of DNA to the Zymo-SpinTM Column, which contains silica 
(Figure 3).  Binding buffer volume was approximately twice the extract volume, as 
dictated by Zymo kit protocol.  The extract was vortexed well with the binding buffer and 
loaded onto the silica spin column, located in a 1.5mL microfuge tube.  The column was 
then centrifuged at 12,000 rpm for one minute, during which DNA was bound to silica 
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contained within the spin column, while impurities flowed through into the microfuge 
tube. 
 
Figure 3.  Spin Column 
The Zymo-SpinTM Column collects DNA on a silica membrane while 
cellular “junk” flows through, allowing for purification and concentration 
of DNA. 28 
 
After the binding step, the column was washed twice with the Zymo DNA Wash 
Buffer to remove any residual DNA contaminants.  DNA was eluted from the silica 
column with 30μl of TE-4 at 65°C (10μM Tris-Cl, pH 8.0 with 0.1μM EDTA).g  Storing 
DNA in TE-4 rather than water prevents some DNA damage from long-term storage.  
Elution was performed in two steps: 15μl of hot (65°C) TE-4 was added to the Zymo-
SpinTM Column, to elute the DNA during a one-minute incubation at 65°C.  The column 
was then centrifuged for 1 minute at 12,000 rpm, and the process was repeated for a final 
                                                
 
g Tris maintains the pH of a solution, while EDTA prevents DNA degradation by 
chelating metal ions like Mg2+ that may otherwise catalyze the hydrolysis of DNA.29,30  
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volume of 30μl.  The extract was immediately quantitated (section 3.4 Quantitation) then 
stored at 4°C. 
Using DEXPAT decreases the amount of time necessary for a typical extraction 
process by eliminating an initial deparaffinizing step, which typically includes a 
Xylene/alcohol washing process and also requires allowing time for the tissue to dry after 
wax is removed.  Traditional extraction is done with phenol and chloroform in a multi-
step purification and centrifugation process (Figure 4).   
 
Figure 4.  Extraction Methods 
Comparison of DEXPAT extraction with conventional extraction 
methods.  DEXPAT eliminates the preliminary deparaffinizing 
step. 
 
3.4. Quantitation 
Following extraction, DNA recovered from the biopsy tissues immediately 
underwent one of two quantitation procedures to estimate the total amount of DNA 
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present.  These two procedures are fundamentally different; yet seek to accomplish the 
same goal.   
The first method, the Quantitative Template Assay Technology (Q-TAT), is an 
end-point quantitative technique developed at CHS. 31,32 End-point methods quantitate 
DNA in a sample after is has undergone PCR amplification.  Q-TAT allows a scientist to 
determine the amount of DNA in an unknown sample by comparing the fluorescence of 
several amplicons produced by the sample to that produced by a DNA standard.  Q-TAT 
primers amplify the amelogenin (or AMEL) locus on the X and Y chromosome, which 
means they can also act in a sex-typing function.  Sex typing can be useful as a 
preliminary examination step when two potential donors for a suspected contaminated 
sample are different genders.  Furthermore, Q-TAT results can predict the state of 
degradation of DNA in a sample. 34,33   
The second quantitative method used in this study was Real Time PCR using the 
Quantifiler kit from Applied Biosystems (Foster City, CA), also called qPCR to indicate 
its quantitative function. While Q-TAT requires a post-amplification capillary 
electrophoresis step to estimate the quantity of DNA present in a sample, a Real Time 
PCR system determines DNA quantity as the reaction progresses; qPCR is therefore a 
somewhat faster technique.  Real Time PCR was performed with the Quantifiler© Human 
DNA Quantification Kit from Applied Biosystems (Foster City, CA).   
Comparing these two methods may offer insight into the nature of DNA 
recovered from FFPE tissues, as both techniques offer unique advantages.  The method of 
detecting inhibition inherent in Q-TAT can suggest at a glance that a PCR reaction is 
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inhibited, while qPCR is known for its accuracy and tracks the kinetics of a PCR reaction 
as it progresses.33 
3.4.1. Quantitative Template Assay Technology (Q-TAT) 
Setting up a reaction for QTAT may not differ noticeably from a Real Time 
reaction at first glance, however Q-TAT differs from Real Time PCR in a number of 
ways, the first of which will be discussed in this section.  While both methods rely on the 
same basic components common to all PCR reactions, primers used in Q-TAT select for 
different genomic target sequences than those in qPCR.  Additionally, these primers have 
been tagged with the fluorescent dye FAM, which allows a genetic analyzer to determine 
the amount of DNA present in a sample based upon the amount of fluorescence a PCR 
product emits.  
Aside from the two AMEL X and Y primers, Q-TAT includes two additional 
primers designed to specifically quantify male or female nuclear DNA.  On the Y 
chromosome, the SRY gene is targeted to identify male DNA, while the HPRT gene 
(labeled HP in Q-TAT electropherograms) on the X chromosome can estimate the 
quantity of female DNA in a mixture of male and female DNA.  Also in the primer mix 
are primers targeting two regions of mitochondrial DNA (mtDNA), producing NED-
labeled amplicons of 287 and 97 bp.34 The ample amount of mtDNA in the cell as 
compared to nuclear DNA (nDNA) may offer Q-TAT a unique quantitative advantage 
over methods analyzing strictly nDNA. 
In addition to human-directed primers, a pRL plasmid and primers are added to 
the Q-TAT PCR reaction to detect inhibition.  The pRL plasmid harbors a gene encoding 
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luciferase found in Renila rentiformis.  At 200 base pairs, the plasmid is sized closely to 
the AMEL X and Y genes, yet just different enough to be distinguished.36 If a reaction is 
inhibited, pRL fluorescence will be reduced in the samples, which is easily visualized 
during analysis.  If a DNA sample fails to amplify while pRL can be seen at the expected 
amount, then the scientist can deduce that there is no DNA recovered or that the DNA is 
degraded, rather than attributing the failure to PCR inhibition.  Knowledge of potential 
inhibition is particularly useful in this study because paraffin embedding may contribute 
to inhibition of amplification. 
Q-TAT reactions for extracted DNA samples of unknown quantity were run 
alongside a serial dilution of specific known quantities.  The relative fluorescent units 
(RFUs) of the known quantities are used to form a standard curve (Figure 5). 
 
Figure 5: HP Standard Curve 
The serially diluted known DNA quantities are used to generate a standard curve.  
A high R2 value indicates the sample points closely adhere to the plot line, where 
a value of 1.0 is perfect adherence.  R2 values for HP were superior to those for 
AMEL and SRY for most Q-TAT amplifications. 
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Fluorescence in extracted unknowns was compared to the standard curve, and an 
estimation was made as to their respective DNA quantities.  Running the standards with 
every set of unknown samples helps to minimize variation between standards and 
unknowns due to mechanical errors.  The standard dilutions were prepared from stock 
male DNA, previously quantitated at 100ng/λ.  This stock was diluted 1:100 with DI 
water to make the 1000pg/µL standard, and then 7.5µL were added to 7.5µL DI water in 
a 0.2mL PCR reaction tube, to make the other 2-fold serial dilution of DNA for the 
standard curve.  Serial dilutions yielding 500ng/µL, 250ng/µL, 125ng/µL, 62.5ng/µL, 
and 31.25ng/µL were created with a 0ng/µL negative control. 1µL of each serially diluted 
sample was added to a new PCR reaction tube and amplified in the Q-TAT assay.  
Each unknown or standard DNA sample was amplified in a PCR tube with 1µL of 
extracted DNA and 11.5µL of a master mix consisting of 1.75µL of water, 1.25µL10x 
primers, 0.5-1pg of pRL DNA in a 1µL volume, and 7.5µL Hot Start GoTaq 
amplification mix (Promega Corp, Madison, WI).  This master mix was prepared, then 
11.5µL aliquots were dispensed to the DNA samples.  The Taq polymerase was a hot-
start variety (Promega Corp, Madison, WI) to reduce the potential for non-specific primer 
annealing, which can occur at lower temperatures.36 
After each sample was prepared it was vortexed.  If liquid adhered to the tube 
wall as a result of vortexing, the sample was spun in a microfuge.  Tubes were then 
placed in an ABI 9700 thermocycler (Applied Biosystems, Foster City, CA).  Cycling 
conditions for the Q-TAT assay are summarized below in Figure 6.  
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Figure 6: Q-TAT PCR Amplification Parameters 
Q-TAT begins with a heating step at 98°C for 2 minutes to activate 
the Taq polymerase.  Then the actual cycling begins with a 10 second 
step at 98°C, followed by a temperature drop to 55°C for 1 minute.  
Because DNA primers are highly concentrated in the solution, they 
bind to the template DNA as it is cooled.  The third step in the cycle 
is at 72°C for 30 seconds, which allows for extension of the primers 
by addition of dNTPs.  This tri-step cycle is repeated 22 times.  After 
cycle completion, the thermocycler holds the DNA samples at 60°C 
for 10 minutes, then 23°C indefinitely. 
 
3.4.1.1. Capillary Electrophoresis 
PCR products, or amplicons, were prepared for analysis on the ABI 310 genetic 
analyzer (Applied Biosystems Inc, Foster City, CA) by adding 1µl of the amplicon to 
24µl of a 1:100 Liz/Formamide Hi Di solution (GeneScanTM 500 LIZ TM Size Standard by 
Applied Biosystems, Foster, CA).  Samples were mixed in 750µl tubes and placed in an 
ABI 310 sample tray. 
Once the sample tray was prepared, samples were analyzed on an Applied 
Biosystems 310 Genetic Analyzer.  The ABI 310 separates amplicons in each sample 
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tube electrophoretically, and captures the fluorescence (RFU) of the amplicons.  The 
GeneMapper ID software (ver. 3.2) was used to analyze the ABI 310 results.  By reading 
the RFU of an individual amplicon in a sample and comparing it to the standard curve, 
the amount of DNA present in the original DNA extract can be determined.   
GeneMapper ID labels each amplicon in a Q-TAT result with peak height and 
peak area fluorescence.  We chose to quantify based upon peak area, as it revealed more 
consistent and accurate results (higher R2 values) than peak height.  Values for each 
amplicon in each sample in the standard curve were entered into an excel spreadsheet 
(Appendix A).  This spreadsheet also allowed for the input of unknown RFU values and 
compared the RFU of unknowns to the standard curve, producing an estimated DNA 
quantity.  In this way, quantities were assigned to unknowns for the AMEL X and Y, 
SRY, and HP loci 
3.4.2. Real Time 
This real time qPCR kit (Quantifiler Human DNA Quantification Kit, Applied 
Biosystems Inc, Foster City, CA) includes a proprietary primer mix, stock DNA at 
200ng/µL, and a PCR reaction mix containing dNTPs.  Similarly to Q-TAT, real time 
amplification requires the generation of a standard curve from known quantities of DNA 
to estimate the DNA quantity in unknowns.  This curve is prepared in much the same 
manner as the Q-TAT curve, but the reagent concentrations differ slightly. 
10µL of stock DNA from the Quantifiler kit is added to 30µL of TE-4 to make a 
50ng/µL sample (a 4X dilution factor).  10µL of this pipette-mixed solution is added to 
20µL of TE-4, resulting in a 16.7ng/µL sample (a 3X dilution factor).  This serial dilution 
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then continues at 3X dilutions, with 10uL of the 16.7ng/µL added to 20µL TE-4, and so 
on, yielding known samples of 5.56ng/µL, 1.85ng/µL, 0.62ng/µL, 0.21ng/µL, 
0.068ng/µL, and 0.023ng/µL.  Finally, 1.2µL of each serially diluted sample is added to a 
separate well in a 0.2ml MicroampTM Optical 8-tube Strip.  Likewise, 1.2µl of each 
unknown extract is added into wells on a separate strip. 
The master mix for qPCR was prepared in such a way that the final reaction 
volume totals 15µL.  This called for 7.5µL reaction mix and 6.3µL primers to be added to 
a master mix for each sample, plus about 10% extra to allow for error.  This is a deviation 
from the kit instructions, which recommend 10.5µL Quantifiler Human Primer Mix, 
12.5µL Quantifiler PCR Mix, and 2µL sample for a total reaction volume of 25µL.  
Using reduced reagent amounts can lead to poor results, which was found to be the case 
in early experimental runs.  These runs were conducted at total reaction volume of 10µL; 
after several runs produced poor results the reaction volume was increased to 15µL, 
which proved small enough to reduce reagent use thereby preventing unnecessary 
expenses, yet large enough to produce consistent results.  Only runs at 15µL were 
reported. 
After 13.8µL of the master mix was added to each sample, the tubes were capped 
with a MicroampTM Optical 8-Cap Strip, which snaps into the top of each tube in the 
strip.  Each 8-tube strip was vortexed and centrifuged before amplification (Figure 7). 
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Figure 7 Real Time qPCR Amplification Parameters 
Real time begins with a heating step at 95°C for 10 minutes.  Then the actual 
cycling begins with a 15 second step at 95°C, followed by a temperature drop to 
60°C for 1 minute.  Due to the short amplicons it produces, real time qPCR can 
combine annealing and extension into this one 60°C step and therefore does not 
need to include a mid-range temperature like that seen in Q-TAT (Figure 6) into 
the cycling. 
3.5. Experimental Control 
The standard curve samples serve as experimental controls, and were amplified 
alongside all unknown DNA samples.  The zero value in the Q-TAT known samples 
served as a negative control, and each of the other six samples served as positive controls.  
Negative controls act to ensure that the procedure has not been contaminated by any 
outside sources, such as experimenter DNA.  If the negative control shows evidence of 
biological material, this indicates that other samples in the same run may also be 
contaminated.  Over the course of this research, no negative controls suggested 
contamination.  A positive control acts as a check on the reagents and processes of a 
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reaction.  It contains a known sample or value that, if incorrectly processed, will indicate 
that other samples may not yield accurate values.
  Chapter	  IV	  
Results	  
4.1. Measurement 
For each sample the total tissue area, as well as the area of the surrounding wax, 
was measured.  Accurate measurement of tissue area was difficult for several reasons: 
Most tissues were of an irregular shape, requiring a meticulous analysis of area, or 
regular shape that allowed for a general length by width measurement.  In this study, a 
general measurement was perceived to be the most efficient measurement method for all 
samples given time constraints.  Only a marginal benefit was expected with more 
accurate, yet laborious, measurements.  Aside from tissue shape, tissue transparency also 
complicated measurement by making the discernment between tissue and wax sometimes 
almost imperceptible.  Lastly, a few biopsies—originating from liver or colon tissues—
possessed a spotted or speckled appearance, rendering even fastidious measurements 
imprecise because most spots were smaller than the lower limit of the measuring tool 
used.
 Several alternatives to measuring with a ruler were proposed, but none were 
deemed to be superior.  One alternative included tracing an outline of the tissue on paper, 
then cutting out the outline and weighing it.  However, this would not remedy the 
transparent tissue problem.  Another alternative was to use a computer program to 
measure scanned images of the tissue, but such a program was not readily available nor 
allowed for in the budget. 
Again, due to a limited benefit from more exact measurements, the original ruler 
method was perpetuated.  This decision does leave room for improvement in future 
research.  The ruler method was consistently applied, thus providing some degree of 
reliable comparison between extracts.  Measurements were as follows: 
Table 2 Slice Measurements 
Sample	  
Type	   ID	  
Block	  
Surface	  
(cm)	  
Section	  Dimensions	  in	  cm	  (all	  0.001cm	  thick)	  
(Replicate	  slices	  used	  for	  DNA	  extraction)	  
Tissue	  
Area	  
(cm3)	  
Excess	  
Wax	  
(cm3)	  
Colon	   3968	   3.0	  X2.2	  	   2.4	  X1.6	  	   2.5	  X1.2	  	   2.5	  X1.5	  	   2.5	  X1.5	  	   2.2	  X1.7	  	   0.01808	   0.01492	  
Colon	   3968	   3.0	  X2.1	  	   2.7	  X1.4	  	   2.3	  X1.5	  	   2.5	  X1.5	  	   2.4	  X1.3	  	   2.3	  X1.5	  	   0.01755	   0.01395	  
Colon	   5040	   1.3	  X1.5	  	   0.2	  X0.2	   0.2	  X0.25	  	   0.2	  X0.2	  	   0.2	  X0.2	  	   0.2	  X0.2	  	   0.00021	   0.00954	  
Colon	   7464	   1.2	  X1.25	  	   0.8	  X0.5	  	   0.7	  X0.8	  	   0.8	  X1.0	  	   0.8	  X0.8	  	   0.7	  X0.8	  	   0.00296	   0.00454	  
Colon	   7464	   1.2	  X1.2	  	   0.5	  X0.7	  	   0.7	  X0.7	  	   0.7	  X0.7	  	   0.6	  X0.6	  	   0.6	  X0.7	  	   0.00211	   0.00509	  
Colon	   6294	   3.0	  X2.1	  	   1.5	  X1.0	  	   1.5	  X1.0	  	   1.5	  X1.0	  	   1.5	  X1.3	  	   1.2	  X1.0	  	   0.00765	   0.02385	  
Colon	   6294	   2.7	  X2.2	  	   1.9	  X1.2	  	   1.5	  X1.2	  	   1.5	  X1.3	  	   1.6	  X1.0	  	   1.5	  X1.0	  	   0.00913	   0.02057	  
Colon	   7057	   2.7	  X2.2	  	   1.5	  X1.2	  	   1.7	  X1.1	  	   1.7	  X1.2	  	   1.5	  X1.2	  	   1.6	  X1.1	  	   0.00927	   0.02043	  
Colon	   7057	   2.7	  X2.2	  	   1.4	  X1.4	  	   2.0	  X1.4	  	   1.7	  X1.3	  	   1.5	  X1.5	  	   1.4	  X1.3	  	   0.00905	   0.02065	  
Breast	   2163	   3.5	  X2.35	  	   2.1	  X1.7	  	   2.2	  X1.7	  	   2.2	  X1.7	  	   2.2	  X1.7	  	   2.2	  X1.7	  	   0.01853	   0.02260	  
Breast	   2163	   3.3	  X2.2	  	   2.2	  X1.7	  	   2.2	  X1.8	  	   2.3	  X1.8	  	   2.2	  X1.8	  	   2.3	  X1.8	  	   0.01994	   0.01636	  
Breast	   2163	   3.2	  X2.2	  	   2.2	  X2.1	  	   2.2	  X2.1	  	   2.1	  X2.0	  	   2.0	  X2.2	  	   2.1	  X2.0	  	   0.02204	   0.23426	  
Breast	   2163	   3.2	  X2.2	  	   2.3	  X2.0	  	   2.3	  X2.1	  	   2.3	  X2.0	  	   2.3	  X2.1	  	   2.2	  X2.0	  	   0.02326	   0.23304	  
Breast	   2445	   2.8	  X2.2	  	   2.7	  X1.3	  	   2.8	  X1.3	  	   2.7	  X1.4	  	   2.7	  X1.5	  	   2.7	  X1.4	  	   0.01876	   0.01204	  
Breast	   2445	   2.7	  X2.4	  	   2.7	  X2.1	  	   2.5	  X2.0	  	   2.5	  X2.0	  	   2.6	  X1.9	  	   1.9	  X2.2	  	   0.02236	   0.01004	  
Breast	   2445	   2.9	  X2.3	  	   2.6	  X2.0	  	   2.6	  X1.8	  	   2.5	  X2.0	  	   2.5	  X1.8	  	   2.5	  X1.7	  	   0.02363	   0.00972	  
Breast	   2445	   2.8	  X2.3	  	   2.5	  X1.5	  	   2.5	  X1.8	  	   2.5	  X1.6	  	   2.5	  X1.8	  	   2.6	  X1.8	  	   0.02143	   0.01077	  
Breast	   2445	   3.0	  X2.3	   2.8	  X1.5	  	   2.8	  X1.5	  	   2.9	  X1.4	  	   2.8	  X1.5	  	   2.9	  X1.5	  	   0.02101	   0.01349	  
Breast	   5511	   3.6	  X2.2	  	   2.3	  X1.6	  	   2.3	  X1.7	  	   2.1	  X1.6	  	   2.4	  X1.7	  	   2.4	  X1.7	  	   0.01911	   0.02049	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Sample	  
Type	   ID	  
Block	  
Surface	  
(cm)	  
Section	  Dimensions	  in	  cm	  (all	  0.001cm	  thick)	  
(Replicate	  slices	  used	  for	  DNA	  extraction)	  
Total	  
Tissue	  
Area	  
(cm3)	  
Excess	  
Wax	  
(cm3)	  
Breast	   5511	   3.4	  X2.3	  	   2.5	  X1.2	  	   2.0	  X1.5	  	   2.4	  X1.4	  	   2.5	  X1.4	  	   2.5	  X1.0	  	   0.01536	   0.02374	  
Breast	   5511	   3.3	  X2.0	  	   2.2	  X1.6	  	   2.3	  X1.7	  	   2.3	  X1.6	  	   2.3	  X1.7	  	   2.3	  X1.6	  	   0.0187	   0.0143	  
Breast	   6811	   2.4	  X2.2	  	   2.4	  X1.3	  	   2.2	  X1.3	  	   2.3	  X1.3	  	   2.2	  X1.3	  	   2.2	  X1.4	  	   0.01491	   0.01149	  
Breast	   6811	   2.8	  X2.4	  	   2.5	  X1.4	  	   2.4	  X1.4	  	   2.4	  X1.3	  	   2.4	  X1.2	  	   2.4	  X1.3	  	   0.01598	   0.01762	  
Lung	   243	   1.1	  X1.1	  	   0.6	  X0.6	  	   0.6	  X0.6	  	   0.6	  X0.7	  	   0.6	  X0.7	  	   0.7	  X0.7	  	   0.00205	   0.004	  
Lung	   243	   1.2	  X1.1	  	   0.6	  X0.6	  	   0.5	  X0.6	  	   0.7	  X0.6	  	   0.5	  X0.7	  	   0.5	  X0.7	  	   0.00178	   0.00482	  
Lung	   5266	   3.5	  X2.3	  	   2.6	  X1.2	  	   2.7	  X1.5	  	   2.7	  X1.3	  	   2.5	  X1.2	  	   2.7	  X1.3	  	   0.01719	   0.02306	  
Lung	   5266	   3.1	  X2.9	  	   2.5	  X1.2	  	   2.6	  X1.3	  	   2.4	  X1.2	  	   2.6	  X1.3	  	   2.7	  X1.2	  	   0.01588	   0.02907	  
Lung	   5266	   3.1	  X2.9	  	   2.6	  X1.2	  	   2.6	  X1.4	  	   2.6	  X1.4	  	   2.6	  X1.2	  	   2.5	  X1.3	  	   0.01677	   0.02818	  
Lung	   5266	   3.5	  X2.2	  	   2.8	  X1.5	  	   2.7	  X1.5	  	   2.6	  X1.5	  	   2.6	  X1.2	  	   2.6	  X1.2	  	   0.01839	   0.02011	  
Lung	   6829	   2.8	  X2.2	  	   1.9	  X1.8	  	   1.8	  X1.8	  	   1.8	  X1.8	  	   1.9	  X1.8	  	   1.9	  X1.8	  	   0.01674	   0.01406	  
Lung	   6829	   2.7	  X2.4	  	   1.8	  X1.8	  	   1.8	  X1.8	  	   1.8	  X1.8	  	   1.8	  X1.8	  	   1.8	  X1.8	  	   0.0162	   0.0162	  
Lung	   6849	   1.2	  X1.1	  	   0.4	  X0.4	  	   0.4	  X0.4	  	   0.4	  X0.5	  	   0.4	  X0.5	  	   0.4	  X0.5	  	   0.00092	   0.00568	  
Lung	   6849	   1.2	  X1.2	  	   0.7	  X0.5	  	   0.5	  X0.6	  	   0.5	  X0.6	  	   0.4	  X0.6	  	   0.6	  X0.5	  	   0.00149	   0.00571	  
Liver	   468	   2.7	  X2.2	  	   2.7	  X2.2	  	   2.7	  X2.2	  	   2.7	  X2.2	  	   2.7	  X2.2	  	   2.7	  X2.2	  	   0.0297	   0	  
Liver	   468	   2.8	  X2.2	  	   2.8	  X2.2	  	   2.8	  X2.2	  	   2.8	  X2.2	  	   2.8	  X2.2	  	   2.8	  X2.2	  	   0.0308	   0	  
Liver	   4681	   0.8	  X1.2	  	   0.8	  X0.5	  	   0.8	  X0.4	  	   0.4	  X0.7	  	   0.8	  X0.5	  	   0.3	  X0.7	  	   0.00161	   0.00319	  
Liver	   4681	   1.2	  X0.9	  	   0.6	  X0.2	  	   0.7	  X0.2	  	   0.4	  X0.4	  	   0.3	  X0.3	  	   0.7	  X0.3	  	   0.00072	   0.00408	  
Liver	   4792	   2.2	  X2.0	  	   1.5	  X1.2	  	   1.4	  X1.3	  	   	  	   	  	   	  	   0.00362	   0.00518	  
Liver	   4792	   2.2	  X2.0	  	   1.2	  X1.3	  	   1.4	  X1.5	  	   	  	   	  	   	  	   0.00226	   0.00654	  
Liver	   4792	   2.2	  X2.0	  	   1.2	  X1.4	  	   1.2	  X1.2	  	   	  	   	  	   	  	   0.00312	   0.00568	  
Liver	   4792	   2.2	  X2.0	  	   1.3	  X1.1	  	   1.1	  X1.2	  	   	  	   	  	   	  	   0.00275	   0.00605	  
Liver	   5178	   2.3	  X2.4	  	   1.8	  X1.4	  	   1.9	  X1.4	  	   1.8	  X1.4	  	   	  	   	  	   0.0077	   0.00886	  
Liver	   5178	   2.3	  X2.5	  	   2.0	  X1.5	  	   1.8	  X1.5	  	   1.7	  X1.2	  	   	  	   	  	   0.00774	   0.00882	  
Liver	   5178	   2.3	  X2.1	  	   1.7	  X1.1	  	   1.9	  X1.1	  	   1.2	  X1.3	  	   1.9	  X1.1	  	   1.8	  X1.2	   0.00977	   0.01438	  
Brain	   147	   1.3	  X1.3	  	   0.8	  X0.4	  	   0.6	  X0.4	  	   0.6	  X0.4	  	   0.7	  X0.4	  	   0.7	  X0.3	  	   0.00129	   0.00716	  
Brain	   147	   1.3	  X1.3	  	   0.7	  X0.4	  	   0.7	  X0.3	  	   0.7	  X0.4	  	   0.7	  X0.3	  	   0.7	  X0.4	  	   0.00126	   0.00719	  
Kidney	   39	   1.3	  X1.0	  	   0.7	  X0.5	  	   0.6	  X0.3	  	   0.7	  X0.7	  	   0.8	  X0.5	  	   0.4	  X0.2	  	   0.0015	   0.005	  
Kidney	   39	   1.2	  X1.0	  	   0.7	  X0.5	  	   0.9	  X0.5	  	   0.4	  X0.6	  	   0.7	  X0.4	  	   0.5	  X0.3	   0.00147	   0.00453	  
“Block surface” includes all wax on the slide, representing the surface of the block from 
which the section was taken.  The “section dimensions” refer to the area of tissue 
sections alone, not including wax.  Five replicate slices were used for most extracts and 
each tissue section is represented in the table, while an average block surface area is 
listed due to very little variation.  Samples 3968 and 7464 were classified as “spotted”, 
meaning tissue was not consistently solid throughout the sample. 
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4.2. Q-TAT Quantities 
Based on the standard curve generated with each run, unknown samples were 
quantitated with Q-TAT at the AMEL X and Y, SRY, and HP loci.  Results for HP were 
consistently superior to other loci, and are thus the only results reported.  One explanation 
for getting results with HP rather than AMEL may be that the DNA is degraded. This is 
expected given the fixation sections undergo as part of their processing.  Furthermore, the 
acidic H&E stain is commonly applied to tissues (although not the ones used in this 
study) offering a further opportunity for degradation.  These reasons will be discussed 
further in section 5.1 Q-TAT.  HP results were as follows: 
Table 1 DNA Quantities for Q-TAT (HP) and Real Time qPCR 
Tissue	  
Type	   ID	  
DNA/μL	  of	  
extract*	  
Total	  
DNA	  (pg)	  
Q-­‐TAT	  
pg	  
DNA/mm3	  
tissue	  Q-­‐
TAT	  
Total	  DNA	  
(pg)	  
qPCR	  
pg	  DNA/	  
mm3	  
tissue	  
qPCR	  
COLON	   3968	   30.333	   910	   167.77	   104.80	   579.65	  
COLON	   3968	   38.067	   1142	   216.90	   80.80	   460.40	  
COLON	   5040	   IND	   <32	   IND	   1.14	   544.76	  
COLON	   7464	   10.800	   324	   364.86	   3.12	   105.27	  
COLON	   7464	   48.800	   1464	   2312.80	   41.60	   1971.56	  
COLON	   6294	   16.033	   481	   209.59	   51.20	   669.28	  
COLON	   6294	   23.600	   708	   258.49	   29.88	   327.27	  
COLON	   7057	   76.417	   2292.5	   824.34	   48.00	   517.80	  
COLON	   7057	   123.550	   3706.5	   1365.04	   46.40	   512.65	  
BREAST	   2163	   21.367	   641	   107.15	   17.28	   86.66	  
BREAST	   2163	   34.833	   1045	   187.98	   50.80	   274.15	  
BREAST	   2163	   10.167	   305	   46.13	   57.60	   261.34	  
BREAST	   2163	   34.400	   1,032	   147.89	   45.20	   194.33	  
BREAST	   2445	   5.967	   179	   31.81	   21.48	   114.50	  
BREAST	   2445	   4.583	   137.5	   20.50	   4.88	   21.82	  
BREAST	   2445	   16.917	   507.5	   71.59	   16.12	   68.22	  
BREAST	   2445	   66.767	   2003	   311.56	   50.40	   235.18	  
BREAST	   2445	   9.933	   298	   47.28	   46.00	   218.94	  
BREAST	   5511	   1.500	   45	   7.85	   15.80	   82.68	  
BREAST	   5511	   IND	   <32	   IND	   6.04	   39.32	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This table lists HP values estimated by the Q-TAT standard curve in column 
“Total DNA (pg) Q-TAT”.  Original DNA quantities were calculated using the 
equation C1V1=C2V2.  Where “<32”pg is reported in the HP column, this means 
that the quantity of unknown DNA fell below the lower limit of detection for the 
ABI 310, and the quantity of original DNA is therefore indeterminable, denoted 
“IND” in the table.  1uL of the extract was amplified in the Q-TAT reaction, and 
1.2 uL in Real Time qPCR.  Extract volume for all samples was 30uL.  A 
normalization of the data is presented in the column “pg DNA/mm3 tissue Q-
TAT”.  The normalization is replicated for Real Time quantities in the far right 
column. 
* Based upon RFU in HP amplicon 
Tissue	  
Type	   ID	  
DNA/μL	  of	  
extract*	  
Total	  
DNA	  (pg)	  
Q-­‐TAT	  
pg	  
DNA/mm3	  
tissue	  Q-­‐
TAT	  
Total	  DNA	  
(pg)	  
qPCR	  
pg	  DNA/	  
mm3	  
tissue	  
qPCR	  
BREAST	   5511	   3.250	   97.5	   17.33	   10.60	   56.53	  
BREAST	   6811	   24.233	   727	   162.53	   22.40	   150.23	  
BREAST	   6811	   237.417	   7122.5	   1485.71	   107.60	   673.34	  
LUNG	   243	   9.367	   281	   456.91	   10.48	   511.22	  
LUNG	   243	   6.183	   185.5	   347.38	   9.80	   550.56	  
LUNG	   5266	   189.100	   5673	   1190.81	   56.00	   352.64	  
LUNG	   5266	   258.733	   7762	   1542.83	   94.00	   560.52	  
LUNG	   5266	   56.700	   1,701	   308.32	   156.80	   852.64	  
LUNG	   5266	   50.700	   1521	   294.94	   114.40	   665.50	  
LUNG	   6829	   34.167	   1025	   210.91	   114.80	   708.64	  
LUNG	   6829	   40.400	   1212	   241.34	   188.80	   1127.84	  
LUNG	   6849	   IND	   <32	   IND	   10.44	   1134.78	  
LUNG	   6849	   23.900	   717	   1604.03	   14.12	   947.65	  
LIVER	   468	   6.067	   182	   20.43	   12.56	   42.29	  
LIVER	   468	   9.017	   270.5	   29.27	   8.04	   26.10	  
LIVER	   4681	   4.000	   120	   248.45	   2.54	   158.01	  
LIVER	   4681	   4.300	   129	   597.22	   0.24	   32.78	  
LIVER	   4792	   3.800	   114	   104.97	   4.28	   118.23	  
LIVER	   4792	   1.633	   49	   72.40	   1.48	   65.43	  
LIVER	   4792	   2.067	   62	   66.24	   0.75	   24.10	  
LIVER	   4792	   1.933	   58	   70.30	   2.10	   76.22	  
LIVER	   5178	   6.400	   192	   69.26	   22.04	   238.53	  
LIVER	   5178	   5.433	   163	   70.56	   33.32	   432.73	  
LIVER	   5178	   30.867	   926	   315.93	   62.40	   638.69	  
BRAIN	   147	   10.400	   312	   806.20	   3.52	   272.87	  
BRAIN	   147	   8.033	   241	   637.57	   12.04	   955.56	  
KIDNEY	   39	   4.567	   137	   304.44	   1.59	   105.87	  
KIDNEY	   39	   5.033	   151	   342.40	   3.26	   221.50	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 HP results are reported preferentially over SRY and AMEL.  When SRY results 
were obtained, the values appear to trend similarly to HP values.  For example, where HP 
results were indeterminable, such as for male sample 5511, SRY results were likewise 
indeterminable.  SRY quantitation results mirrored HP values in terms of whether 
samples produced low or high DNA yield, though the exact values differed. 
4.3. Real Time Quantities 
Real Time quantities required no manipulation after being analyzed by the 7500 
software, results are as produced by the internal analysis, and listed in Table 3 alongside 
Q-TAT HP results. 
A Pearson correlational analysis measures the linearity between two variables.  In 
this study, the analysis was applied to Q-TAT and Real Time results to determine if there 
is a statistically significant difference between the two quantitative methods. This 
analysis yielded a coefficient of 0.49, as seen in Table 4: 
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Table 4: Correlational Analysis of Q-TAT and Real Time Data 
 
Variables in the analysis refer to the quantitative method used, either  
Q-TAT or Real Time PCR.  Because the same extract was quantitated 
using each method, here N does not indicate the number of total extracts, 
but rather the number of quantitations performed. 
 
Here the null hypothesis, H0, is the hypothesis that there is no difference between 
quantitative methods Q-TAT and Real Time, whereas the alternative hypothesis, H1, 
represents the hypothesis that there is a difference between the methods.  The null 
hypothesis is rejected (p=0.0004, α=0.05),.  Thus, there is a significant different in the 
quantitative estimates produced by the two methods. 
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4.3.1. Variance Among Tissue Types 
Looking now at variation among tissue types, only the four main types—breast, 
colon, liver, and lung—were statistically analyzed.h  First, a split-plot analysis of variance 
(ANOVA) was performed, which allows for examination of quantities by tissue type at 
two levels, here the quantitative methods.  The split plot design examines variability at 
two different levels, DNA yield within tissue type, and then among each quantitative 
method.  Tissue type was set up within the split plot design as the main unit factor 
(MUF), and quantitative method (Q-TAT or Real Time) as the split unit factor (SUF).  
Results showed that the variation within tissue types was high.  This is an expected 
conclusion when results are generated as a quantity or amount.  To assuage this variation, 
the original quantitative values were statistically transformed using a square root 
transformation.  The interaction between the MUF and SUF was insignificant, as were 
the main effects, as seen in Table 5: 
                                                
 
h Due to the fact that only one sample was collected of each minor tissue type 
(brain and kidney) no statistical analysis was performed on them.  One sample was not 
considered representative enough of a larger population to draw significant conclusions.  
Moreover, maintaining relatively equal sample numbers among tissue groups (main types 
consisted of either four or five samples) was important in producing a reliable statistical 
analysis. 
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Table 5: Test of Fixed Effects 
 
This test demonstrates that there is no relationship between tissue type and DNA 
yield regardless of quantitative method used, however the absolute values 
between the two methods still differed greatly.    
 
The test of effect slices (Table 6) shows the method by each tissue type, again 
displaying a lack of significance.  
Table 6: Tests of Effects Slices 
 
Showing a breakdown of the tests of fixed effects (Table 5), the tests of 
effects slices reiterates similarities among DNA yield by tissue type. 
 
For each combination of method and type, the means (MNDNA) and standard 
errors (SEDNA) are shown in Table 7.  While at first glance the means do seem very 
different, the statistical method used to analyze this data introduces large standard errors, 
rendering even sizeable differences insignificant.   
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Table 7: Mean and Standard Error 
 
Large MNDNA differences do not equate to statistically significant 
differences after analysis because of the blocking, or arrangement of 
experimental units into subgroups, used in analysis.  The subgroup blocks 
here are the tissue types. 
 
4.3.2. Wax Removal Study 
Three extractions were performed in pairs to examine the effect of removing 
wax on the final DNA yield.  Previous studies indicated that a larger amount of wax 
may result in a reduced yield38, but most wax-removal is simply confined to the 
deparaffinizing step38.  Taking this concept one step farther, wax was physically 
removed from the tissues on glass slides prior to DNA extraction.  Opaque tissues 
with a well-defined border and a solid (rather than spotted) consistency were selected 
to make wax removal as straightforward as possible. 
 Liver tissue 5178, and lung tissue 5266 were tested.  Five slides from each 
tissue were extracted with all wax present, and 5 slides were extracted with as much 
 43 
wax physically removed from the slide as possible.  For the most part, wax separated 
nicely from the tissue border when scraped off the slide with a razor.  The excess wax 
was discarded and tissue was extracted as usual. 
Quantitation results from this wax removal study are as follows: 
Table 8. Wax-Removal Study Quantities 
Sample	  Type	   ID	  
Total	  tissue	  
Area	  of	  
Five	  Slices	  
Total	  
Residual	  
Wax	  of	  Five	  
Slices	  
Mean	  Total	  
DNA	  
Extracted	  
(pg)	  
Liver	   5178	  Pos	   0.0077	   0.00886	   33.32	  
Liver	   5178	  Neg	   0.00774	   0	   56.4	  
Lung	   5266	  Pos	   0.01588	   0.02907	   56.00	  
Lung	   5266	  Neg	   0.01677	   0	   94	  
Results of study comparing extractions performed with and without wax, 
where "Pos" indicates a sample positive for excess wax, and "Neg" 
indicates a sample from which wax has been removed.  DNA quantities 
reported are as quantitated by Real Time PCR. 
 
While more data points are desirable in order to perform a statistical analysis of 
this effect, preliminary results seen here suggest that less residual wax results in a higher 
DNA yield.  
4.3.3. Inhibition Study 
In order to determine if increased DNA yield from wax-negative samples was 
due to reduction of PCR inhibition from paraffin wax, a study was performed using 
sample 5178Pos.  Several dilutions of this sample were run with the Real Time 7500.  
If the calculated DNA yield decreased along with the sample’s dilution, then 
inhibition was determined to be unlikely.  Results in Table 9 do suggest that paraffin 
is unlikely as a factor in decreased yield between wax-positive and wax-negative 
 44 
samples due to PCR inhibition.  Of course, inhibitors may be present during PCR in 
the tissue itself coming from fixation, or in other cases, staining.  Furthermore, 
paraffin wax may still be a source of inhibition in other ways, such as by negatively 
effecting DNA extraction from the cell. 
Table 9. Inhibition Study Series Dilution 
	  Sample	   Dilution	   Quantity	  (ng/uL)	  
5178Pos	   none	   0.606	  
5178Pos	   dil	  2	   0.317	  
5178Pos	   dil	  4	   0.135	  
5178Pos	   dil	  8	   0.0652	  
5178Pos	   dil	  16	   0.0679	  
5178Pos	   dil	  32	   0.0272	  
The steady decrease in DNA quantities with increasing 
dilutions suggests that paraffin wax is not a source of PCR 
inhibition.  Quantitations were done with qPCR. 
 
  Chapter	  V	  
Discussion	  and	  Conclusions	  
Comparing Q-TAT and Real Time qPCR is not a straightforward endeavor.  
While quantitation is the main objective of each method, they differ in the point at which 
they quantitate respective to amplification.  Furthermore, there is not a universal “best” 
choice, as the methods have different strengths.   Discussing and assessing the results 
obtained from each method may help future researchers determine which technique to 
apply in their own research, and offer a look at a practical comparison of end-point and 
qPCR, rather than one inside the confines of a traditional method validation study.  
Ultimately, evaluating a quantitative method for a forensic DNA laboratory will depend 
primarily on being able to produce good STR profiles on a daily basis.  
5.1. Q-TAT 
The strength of end-point PCR, and Q-TAT in particular, lies chiefly in the 
method’s cost efficiency.  Developed “in-house” with custom primers, Q-TAT can be 
performed for much less than qPCR.  For laboratories without a Real Time PCR 
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thermocycler, which are sold in the $40,000 range, the cost of acquiring the equipment 
and necessary reagents may exceed a strict budget.  Q-TAT is an effective alternative to 
quantify DNA yield and can be run for about $9.00 per reaction using common forensic 
laboratory equipment like a thermocycler and genetic analyzer (Maven Analytical, 
Peyton, Colorado). 
Q-TAT is surprisingly flexible as evidenced in this study by the use of the HP 
locus over AMEL and SRY.  The basic gender-typing function is unique to the method 
and can certainly be useful when seeking to identify contamination. In this study, the 
results obtained with the HP locus were superior to those at the X and Y loci, as indicated 
by the consistently higher R2 value in the HP standard curve.  The HP locus may have 
performed better due to its smaller size: it is roughly 100bp smaller than the AMEL X 
and Y loci.i 33 Where degradation is a concern, as it is with aged or embedded samples, 
longer genomic fragments tend to break down more quickly than smaller fragments, and 
its smaller size would therefore offer HP some protection against degradation, though 
certainly not immunity.  The pRL plasmid in Q-TAT is an effective indicator of 
inhibition and has been shown to be extremely sensitive.36  
As with most scientific methods, some sacrifices must be made in the name of 
cost-efficiency, and end-point PCR is no exception to this rule.  Taking post-
amplification quantitative measurements has been shown to have an inherently higher 
                                                
 
i AMEL-X is 210 bp in length and AMEL-Y 216 bp, while the HPRT gene is 99 
bp.33 
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coefficient of variability than that claimed for qPCR which we found to be true as well 
(results not shown).7 The reported coefficient of variation for Q-TAT is around 35%.31 
For many research endeavors—including STR profiling—this rate is acceptable.  
However, studies with a focus on more precise quantitation may call for a more exact 
technique. 
5.2. Real Time 
Speed and amplification efficiency are two highlights when considering Real 
Time PCR for research use.  The 7500 measures the efficiency of an amplification 
reaction based on the threshold cycle (CT) of known DNA samples.  This cycle is the 
amplification cycle number at which the accumulation of RFU from an amplicon 
logarithmically increases with each successive cycle.  Efficiency is determined by 
plotting CT for each dilution in the standard curve against a log DNA concentration, 
giving a slope of -3.32 at 100% efficiency.40 As long as the slope is close to -3.3, 
efficiency is considered optimalj (see Figure 8).  This slope can be improved by using a 
broader range of standards, and acts as an internal control for PCR inhibitors as they will 
reduce efficiency.  
                                                
 
j Amplification efficiency is a vital indicator in quantitation procedures, as 
consistent efficiency in all samples is necessary for reliable comparison.  Invariable 
amplification becomes even more important when comparing known to unknown 
samples, as seen in this research and in most crime lab quantitative procedures.  
Differences in reference and target DNA can result in the under- or over-estimation of the 
actual DNA quantities. 40 
 48 
The utility of Real Time qPCR can be increased by using primers that allow for 
detection of DNA degradation.  Pairing a primer for a longer target sequence (150-200 
bp) with one for a shorter amplification target (50-80 bp), as in Q-TAT, can suggest 
degradation in cases where the shorter sequence is amplified more than the longer 
sequence.  This approach is based on the theory that longer DNA fragments degrade 
faster than shorter fragments.42 
 
Figure 8: Efficiency Plot 
Efficiency of a Real Time PCR reaction with CT values plotted on the Y-
axis against the log of the DNA concentration on the X-axis.  The slope 
here of -3.3 indicates optimal reaction efficiency. The curve is fit by the 
Sequence Detection  Software (SDS) version 1.2.3.40 
  
The closed-tube system of qPCR also benefits an amplification reaction, as post 
PCR processing can allow for pipetting variability or introduce contamination into the 
quantitation procedure.43  
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Real Time is not without its disadvantages, however.  Equipment such as the ABI 
Real Time 7500 can be cost-prohibitive, especially when considering validation and 
maintenance, and the purchase of proprietary reagents.44 Some labs may still consider the 
initial equipment purchase an investment that can be recuperated in the reproducibility of 
results and time saved over end-point PCR. 
5.3. Method Comparison 
A correlational analysis of the quantitation estimates for DNA extracts from 
biological specimens produced using Q-TAT as opposed to Real Time showed the 
estimates to be significantly different, indicating the two methods yield estimates that 
differ.  Statistical analysis only offers insight into the degree to which these two methods 
differ, rather than suggesting a superior quality of one method versus the other.  
Examining differences in these methods can hopefully help lead to a determination as to 
which method is called for in a particular situation.  First, looking at the R2 value can 
suggest a level of reliability for the method.  This value measures the extent to which the 
standard DNA quantities adhere to a line of best fit, where an optimal value is 1.00.  Real 
Time protocol calls for an R2 of no less than 0.98, and all runs were at or above 0.98.  Q-
TAT R2 values for the HP locus were in the range of 0.94 to 0.99.  This is considered an 
acceptable range, but does leave room for improvement.  The difficulty in achieving a 
higher R2 value in Q-TAT necessitates a wider confidence interval for results.   
There are a few reasons why the R2 value for the end-point method may be lower, 
such as the error rate mentioned previously in section 5.1 Q-TAT.  Post-amplification 
processing in end-point requires that samples be manipulated after PCR, when a sizing 
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standard is added to each sample.  This involves pipetting 1µl of the amplicon into a 
clean tube, and mixing it with 24µl of the Liz/Hi-Di solution.  Any additional processing 
step such as this may introduce enough human or mechanical error to account for a lower 
R2. 
A second factor of interest in comparing these two techniques is the point at 
which quantitation is determined.  As an end-point PCR method, Q-TAT establishes a 
quantity for unknown values after the PCR procedure has completed and the amplicons 
are separated and quantitated on a genetic analyzer.  Due to the nature of PCR 
amplification, the quantity of amplicons in identical samples may differ more at the end 
of cycling than at earlier phases.  The early exponential phase of PCR is highly efficient, 
as each cycle exactly doubles the previous.  However, reaction products begin to be 
consumed during the middle linear phase.  Replicates then enter the final plateau phase at 
different rates and may even begin to degrade, resulting in lowered efficiency (Figure 
9).33   
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Figure 9: Quantitation of Replicate PCR Cycles 
The quantity of replicate amplicons is very close during the exponential 
phase, but begins to spread as PCR progresses.35 
 
Real Time PCR essentially resolves this issue by collecting data as soon as the reaction 
crosses the threshold, a point set in the exponential phase.  The CT is typically between 8 
and 35 cycles into the PCR reaction.  As a result of eliminating the post-PCR step, there 
is less chance for contamination and error to be introduced.   
 
5.4. Tissue Type Comparison 
 While it was originally predicted that the density of certain tissues may correlate 
to the yield of recovered DNA, in practice the relationship of tissue type to picograms of 
DNA recovered was not statistically significant.  Due to the great degree of variability in 
quantitative results, a statistical analysis of yield versus tissue type was difficult even 
after applying a square root transformation to the data.  While five sections of tissue were 
used for each extraction, the amount of tissue in each section varied slightly owing to 
inconsistencies in the size of the original biopsy.  Furthermore, variation in DNA yield 
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could be attributed to inconsistent cross-linking and fragmentation rates due to disparities 
in fixation times.  
A large scale study may shed more light on DNA yield versus tissue type, as the 
fairly small sample pool studied here may not offer enough values to determine a reliable 
mean for each tissue group.  Such a study could also be approached by selecting a 
uniformly sized extract from each section, rather than extracting five tissue sections and 
extrapolating an amount of DNA recovered per centimeter based on the measured area of 
the tissue.  Alternatively, stained slides may offer an opportunity to calculate cell density 
prior to extraction and thereby craft a more specific measurement.  Any effects staining 
may have on extraction should be taken into consideration. 
This lack of significance is interesting on a number of levels, and it implies that 
tissue types do not need to be treated differently prior to extraction as previously 
suspected.  This may be important when dealing with unknown tissue types or when 
processing a wide variety of tissues simultaneously.   
 
5.5. Future Research 
Despite some research into the area of DNA extraction from FFPE tissues, more 
work is needed.  There are several avenues yet to explore, chief among them a broader 
tissue-differentiation study.  A laboratory with more time to devote to the study may 
choose to investigate the idea of extraction tailored to tissue type in-depth, rather than the 
cursory level at which it was examined in this study. 
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Building upon the wax-removal study could offer more insight into possible 
benefits of this technique.  Additionally, a study could explore more precise methods of 
removing excess wax, particularly from transparent or spotted tissue samples. 
Enhancing the functionality of qPCR may be a goal for labs choosing to use this 
particular quantitation method, and research into primers that allow for degradation 
detection would benefit the scientific community as a whole.  
Lastly, this study could be replicated using other FFPE extraction kits.  The 
QIAmp DNA FFPE Tissue Kit (Qiagen, Hilden, Germany) is one viable option, and has 
been tested on some sections from the wax blocks that were used in this study.  Early 
results as performed by Dr. Jun Fu (Human Identity Lab, OSU Center for Health 
Sciences) suggest that the QIAmp kit operates at a similar level as DEXPAT for 
incisional biopsies, but may offer improved DNA yield when using tissue samples from 
needle biopsies.  A formal study is needed to generate conclusive results. 
  Appendix	  A	  
Area fluorescence values from the Applied Biosystems 310 GeneMapper software 
were entered into an excel spreadsheet, formulated to create a line of best fit through the 
data, the standard curve line: 
 
Amelogenin X and Y values were summed to generate a Total Human DNA standard 
curve, while SRY and HP values were placed on separate graphs: 
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Using the calculated line equations, unknown values were entered into a separate chart, 
which generated DNA quantities in pg: 
  Appendix	  B	  
Successful DNA extraction from FFPE tissues was important in this study as a 
precursor to quality STR profiling.  Therefore, a profile was developed to demonstrate 
the results that could be expected from biopsy sample, and also to validate quantitation 
results.  The profile below was generated from five sections of lung biopsy sample 6829, 
which consistently yielded DNA quantities sufficient for STR typing.  While this profile 
displays the downward RFU slope characteristic of degradation (as explained in section 
2.5.5 Degradation), the alleles present are still useful for identification purposes.  
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